- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Parker Research Institute
Total 18935 results
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)RecruitingCancer | Insomnia | Insomnia Due to Medical ConditionUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Recruiting
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Active, not recruitingMonoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedLeukemia | Drug/Agent Toxicity by Tissue/OrganUnited States, Canada
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedHematopoietic Cell TransplantationUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedMetastatic Colorectal Cancer | Metastatic Pancreatic Cancer | Unresectable Pancreatic CancerUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedInsomniaUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)TerminatedProstate CancerUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Completed
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States, Germany
-
National Cancer Institute (NCI)Dana-Farber Cancer InstituteWithdrawnHead and Neck Cancer | Lip and Oral Cavity Cancer | Oropharyngeal CancerUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Not yet recruitingSexual Function Disturbances | Cancer SurvivorshipUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)RecruitingStress | AnxietyUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)RecruitingMultiple Myeloma | Weight Loss | Fasting | MGUS | Cancer Prevention | Smoldering Waldenstrom Macroglobulinemia(WM)United States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)RecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Ovarian Cancer Stage IV | Ovarian Cancer Stage III | Fallopian Tube Cancer Stage IV | Fallopian Tube Cancer Stage IIIUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Recruiting
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Recruiting
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedOvarian CancerUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Completed
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)TerminatedDuctal Carcinoma in Situ | Invasive Breast Cancer (Stage I-III) | Lobular Carcinoma in Situ | Lobular Carcinoma | Fatigue Related to Cancer TreatmentUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Completed
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Completed
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedInflammatory Breast CarcinomaUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Myeloma | Graft Versus Host DiseaseUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedSarcoma | Kidney Cancer | Testicular Germ Cell Tumor | Head and Neck Cancer | Ovarian Cancer | Lung Cancer | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Bladder Cancer | Extragonadal Germ Cell Tumor | Carcinoma of Unknown PrimaryUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Completed
-
Dana-Farber Cancer InstituteCompletedPain | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedQuality of Life | Palliative Care | Outcome Assessment | Pediatric NeoplasmUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedSarcoma | Brain and Central Nervous System Tumors | Gastrointestinal Stromal TumorUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)UnknownMelanoma (Skin)United States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)UnknownHead and Neck CancerUnited States
-
Dana-Farber Cancer InstituteImmunityBio, Inc.Not yet recruitingOvarian Cancer | Platinum-resistant Ovarian Cancer | Ovarian Carcinoma | Recurrent Ovary Cancer | Ovarian Carcinoma, RecurrentUnited States
-
Dana-Farber Cancer InstituteNest GenomicsRecruitingGenetic Predisposition to Disease | Genetic PredispositionUnited States
-
Dana-Farber Cancer InstituteCelldex TherapeuticsRecruitingMelanoma | Metastatic MelanomaUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Breast Cancer | Invasive Carcinoma of the Breast | Node Negative Breast Cancer | Micrometastasis Breast CancerUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingAdvanced Non-Clear Cell Kidney CancerUnited States
-
Dana-Farber Cancer InstituteIncyte CorporationActive, not recruitingInflammatory Breast Cancer (IBC)United States
-
Dana-Farber Cancer InstituteRoche-GenentechActive, not recruitingGraft vs. Host DiseaseUnited States
-
Dana-Farber Cancer InstituteHiberCell, Inc.CompletedRelapsed/Refractory Indolent B Cell Non-Hodgkin LymphomasUnited States
-
Dana-Farber Cancer InstituteTesaro, Inc.Active, not recruiting
-
Dana-Farber Cancer InstituteEisai Inc.Active, not recruitingInflammatory Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
Dana-Farber Cancer InstituteAmbry GeneticsCompletedBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Metastatic Prostate CancerUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingChronic Lymphocytic LeukemiaUnited States
-
Dana-Farber Cancer InstituteTakeda; CelgeneActive, not recruitingSmoldering Multiple MyelomaUnited States
-
Dana-Farber Cancer InstituteEntrinsic HealthCompletedMultiple Myeloma | Non-Hodgkin's LymphomaUnited States